Genmab A/S
GNMSF
$241.84
-$3.16-1.29%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 72.31% | -64.51% | 194.55% | -8.10% | 5.73% |
| Total Depreciation and Amortization | 0.00% | -2.65% | -0.42% | 17.89% | 7.69% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -18,600.00% | 100.54% | -207.27% | 70.33% | 317.02% |
| Change in Net Operating Assets | -240.00% | 837.13% | 110.36% | 22.78% | -263.93% |
| Cash from Operations | -78.40% | -25.95% | 29.38% | 36.79% | 0.00% |
| Capital Expenditure | 16.67% | 10.67% | -139.91% | -39.99% | 0.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 100.00% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 216.13% | -223.25% | -34.85% | -92.53% | 350.97% |
| Cash from Investing | 160.47% | -466.93% | -64.50% | 102.60% | -504.76% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -100.00% | -- | 100.00% | -466.67% | 0.00% |
| Issuance of Common Stock | 500.00% | -90.91% | -74.42% | 2,050.00% | -77.78% |
| Repurchase of Common Stock | -3,300.00% | -50.00% | 97.35% | 31.21% | -382.42% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -3,023.08% | -3,132.42% | 101.05% | 90.76% | -417.65% |
| Foreign Exchange rate Adjustments | -162.50% | -92.21% | 2,224.41% | 131.58% | -1,300.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -235.15% | -52.44% | 69.57% | 119.69% | -1,854.55% |